Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

6.60
BATS BZX Real-Time Price
As of 3:21pm ET
 +0.20 / +3.12%
Today’s Change
5.87
Today|||52-Week Range
23.39
-36.42%
Year-to-Date

Today’s Trading

Previous close6.40
Today’s open6.49
Day’s range6.49 - 6.99
Volume72,855
Average volume (3 months)265,051
Market cap$220.5M
Dividend yield--
Data as of 3:21pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+260.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio137.1
Price/Sales9.15
Price/Book2.62

Competitors

 Today’s
change
Today’s
% change
RXDXIgnyta Inc-0.17-2.29%
ENZYEnzymotec Ltd-0.40-4.18%
CGENCompugen Ltd+0.01+0.22%
NSTGNanoString Technolog...-0.07-0.58%
Data as of 3:24pm ET, 02/10/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)$0.06
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Bobby Dwayne Montgomery
Chief Operating Officer
Frank D. Czworka
Corporate headquarters
Columbia, Maryland

Forecasts

Partner Offers